Ace investor Mukul Agrawal acquired a 1.28% stake (3 lakh shares) in Tatva Chintan Pharma Chem Limited during Q1FY26. This small-cap specialty chemicals company, with a market cap of over ₹2,300 crore, maintains a healthy 22% dividend payout. The stock has climbed over 60% from its 52-week low of ₹610 per share.